Anti-MBPK Red, 20X Antibody, Unconjugated from Upstate

Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems

Rabbit Anti-Human ADH5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems

Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)

Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems Rabbit Anti-Human ADH5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)

(Date:11/30/2009)..., New Orleans, LA Researchers from LSU Health Sc... Eunice Kennedy Shriver National Institute of Chil...hool of Public Health, Brigham and Women,s Hospita...first time that drinking more than 5 servings of s...ears to significantly elevate the risk of developi...

(Date:11/30/2009)..., Two so-called invasion proteins are crucial for...surface of human cells, which stimulates the host ...ptor molecules exert a different function, for exa...ng. The group,s results have now been published in...iology ". , Spoiled meat is one of the sources f...

(Date:11/30/2009)..., If you ever thought the stress of seeing your e...g youbad news: a new research report in the Decemb...iology ( http://www.jleukbio.org ) shows that you...m the same study might lead to entirely new treatm..., arthritis, and eczema under control. That,s beca...

Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2 Sugary cola drinks linked for first time to higher risk of gestational diabetes 3 It takes 2 to infect 2 Seeing family for the holidays? Scientists discover how the stress might kill you 2 UCR scientists manipulate ripples in graphene enabling strain based graphene electronics 13195 1 UCR scientists manipulate ripples in graphene enabling strain based graphene electronics 13195 2 UCR scientists manipulate ripples in graphene enabling strain based graphene electronics 13195 3 Surgery remans an option for advanced lung cancer 52719 1 Surgery remans an option for advanced lung cancer 52719 2 Common allergy drug reduces obesity and diabetes in mice 9359 1 Common allergy drug reduces obesity and diabetes in mice 9359 2 Common allergy drug reduces obesity and diabetes in mice 9359 3 Common allergy drug reduces obesity and diabetes in mice 9359 4

[0] Sugary cola drinks linked for first time to higher risk of gestational diabetes [0] It takes 2 to infect [0] Seeing family for the holidays? Scientists discover how the stress might kill you

...rcent of women rely on their healthcare providers ...ercent said their doctor has talked to them about ...avirus (HPV) - according to a new survey released ...onals (ARHP). HPV is extremely common, affecting a...n their lifetime, in some cases staying dormant un...

...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...

Other Biology News:Survey reveals women and doctors aren't talking about HPV 2 Survey reveals women and doctors aren't talking about HPV 3 Health costs soar as 60 million Americans classed as obese 2 UN successfully tests 'green' pesticide against locusts 2

Survey reveals women and doctors aren't talking about HPV Health costs soar as 60 million Americans classed as obese UN successfully tests 'green' pesticide against locusts

(Date:11/30/2009)...RK, Nov. 30 The Michael... today announced $1.5 million in total awards to s...isease-modifying therapies for Parkinson,s disease...hes to Drug Discovery for Parkinson,s Disease pro...on, plc (NYSE: ELN ), a neuroscience-based biote...

(Date:11/30/2009)...STERDAM, November 30 Biopharmaceut...e first patients have been enrolled in its,multina...The study is,designed to show reduction in transpl...ng an allogeneic stem cell transplantation with a ... patients eligible for an allogeneic,stem cell tra...

(Date:11/30/2009)...LLE, Md., Nov. 30 Novava...mpleted enrollment in the Phase II clinical study ...ommended strains) VLP vaccine candidate in healthy...This randomized, double-blind, active-controlled s...unogenicity of two different doses (15 mcg and 60 ...

(Date:11/30/2009)...EATTLE, Nov. 30 Cell The...nced today that its new class of platinum-based an...rated a stronger anti-tumor potency and activity c...ounds as well as the ability to overcome cisplatin...e presented in a paper titled "Novel Bis-platinum ...

Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2 The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3 Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4 New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2 New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3

[0] The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments [0] Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)[0] NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults [0] New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents

Products	Anti-MBPK Red, 20X Antibody, Unconjugated from Upstate
Company	Upstate
Item	Anti-MBPK Red, 20X Antibody, Unconjugated
Price	$359.00
Description	MBPK Antibody - Red, 20X Immunogen Proprietary formulation containing MBPK antibody at 20X concentration for use in KinEASE™ 645nm FarRed fluorescence polarization assays. Quality Assurance Routinely evaluated with KinEASE™ 645nm FarRed fluorescence polarization assays. Stability 6 months at -20°C from date of shipment
Info	Upstate 28820 Single Oak Drive Temecula, CA 92590 Customer Service: 800-437-7500 or 951-676-8080 Tech Support: 800 548-7853 Fax Number: 800-437-7502 or 951-676-9209 Web Site: http://www.upstate.com